Viewing Study NCT03198650

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 4:50 PM

Ignite Modification Date: 2026-01-05 @ 5:30 PM

Study NCT ID: NCT03198650

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2025-10-09

First Post: 2017-06-14

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: A Phase 1 Study of Acalabrutinib in Japanese Adult Patients With Advanced B-cell Malignancies

Sponsor: AstraZeneca

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module